Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The incidence of malaria cases continued to drop dramatically in rural and remote Myanmar villages after community workers trained only to detect and treat malaria began providing basic health care as well as malaria services, say University of Oxford affiliated researchers. Adding the health services to malaria control benefitted the villagers access to health and improved malaria services – paving the way for malaria elimination.

Image courtesy of Shutterstock

Villages where trained community health workers (CHWs) provided malaria diagnosis and treatment experienced a 70% decline in P. falciparumand a 64% drop in P. vivaxmalaria incidence for each year of operation, the scientists say in a study published in BMC Medicine.

But as malaria fell so did the number of people being screened. When community health workers began offering a broader package of health services – including for tuberculosis (TB), respiratory tract infections, malnutrition and diarrhoea, while continuing to screen for malaria – health improved and so did malaria control.

“To maintain effective malaria control in hard to reach areas village health workers were trained both to screen and treat malaria and to handle other common health care needs,” said study author Oxford Prof Frank Smithuis, Director of the Myanmar Oxford Clinical Research Unit (MOCRU) and the NGO Medical Action Myanmar (MAM) in Yangon, Myanmar. 

“This significantly reduced malaria transmission and kept patients coming in to be screened for malaria, which is essential if we are to eliminate malaria in Myanmar,” explained Prof Smithuis. 

The study did a retrospective analysis of over half a million malaria rapid diagnostic tests conducted between 2011 and 2016 by 1,335 CHWs supported by MAMin cooperation with the Myanmar Department of Health. Its results have important implications for Myanmar and other SE Asian countries racing to eliminate malaria.

“This study demonstrates that to eliminate malaria in hard to reach areas, CHWs networks should be offering malaria screening and treatment and basic health care,” said study contributor Mahidol and Oxford University Prof Sir Nicholas White. “Training health workers to just screen for malaria is not sustainable. These CHWs must offer a package for common health problems. This will sustain the popularity of the CHW services, benefit the accessibility of health services for the community and ensure that malaria is eliminated and then stays eliminated.”

“Many of the people we studied lived in communities with no medical care of any kind other than informal local healthcare providers (quacks) and so remote that it could take several days of hard travel to reach them,” said Dr Alistair McLean, lead author. “Offering people in hard-to-reach communities a package of basic quality health services is essential to prevent malaria resurgence.”

The project was funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria, the 3 Millennium Development Goal Fund, Planet Wheeler Foundation, Kadoorie Charitable Foundation, DAK Foundation, and The Wellcome Trust (UK). 

MOCRUis the Myanmar Unit of the Mahidol Oxford Tropical Medicine Research Unit (MORU), a Wellcome-funded tropical health network based in Bangkok, Thailand.

Similar stories

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Major funding for Oxford will help find new cancer treatments

Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.

Molnupiravir doesn't reduce COVID-19 hospitalisations in high-risk vaccinated people

Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.

Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment

New research from the MRC Weatherall Institute of Molecular Medicine has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.